Integra Lifesciences Holdings (IART) Shareholder's Equity Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.38% |
| Dec 31, 2025 | -7.18% |
| Sep 30, 2025 | -5.79% |
| Jun 30, 2025 | -5.10% |
| Mar 31, 2025 | 2.58% |
| Dec 31, 2024 | 1.75% |
| Sep 30, 2024 | 1.90% |
| Jun 30, 2024 | 1.55% |
| Mar 31, 2024 | 2.72% |
| Dec 31, 2023 | 2.91% |
| Sep 30, 2023 | 2.96% |
| Jun 30, 2023 | 4.64% |
| Mar 31, 2023 | 10.90% |
| Dec 31, 2022 | 13.40% |
| Sep 30, 2022 | 13.56% |
| Jun 30, 2022 | 13.17% |
| Mar 31, 2022 | 13.63% |
| Dec 31, 2021 | 14.94% |
| Sep 30, 2021 | 14.66% |
| Jun 30, 2021 | 14.66% |
| Mar 31, 2021 | 14.52% |
| Dec 31, 2020 | 15.05% |
| Sep 30, 2020 | 13.87% |
| Jun 30, 2020 | 13.64% |
| Mar 31, 2020 | 14.29% |
| Dec 31, 2019 | 15.00% |
| Sep 30, 2019 | 15.09% |
| Jun 30, 2019 | 15.57% |
| Mar 31, 2019 | 15.52% |
| Dec 31, 2018 | 15.61% |
| Sep 30, 2018 | 22.27% |
| Jun 30, 2018 | 21.04% |
| Mar 31, 2018 | 14.39% |
| Dec 31, 2017 | 13.20% |
| Sep 30, 2017 | 11.63% |
| Jun 30, 2017 | 12.02% |
| Mar 31, 2017 | 10.89% |
| Dec 31, 2016 | 11.25% |
| Sep 30, 2016 | 10.42% |
| Jun 30, 2016 | 8.90% |
| Mar 31, 2016 | 8.03% |
| Dec 31, 2015 | 8.49% |
| Sep 30, 2015 | 9.17% |
| Jun 30, 2015 | 9.10% |
| Dec 31, 2014 | 9.62% |